Company Filing History:
1 out of 856 
1 out of 8 
1 out of 1,035 
Years Active: 2022
Title: Masahiro Miura: Innovator in Monoclonal Antibody Research
Introduction
Masahiro Miura is a prominent inventor based in Kobe, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for various medical applications, especially in understanding and treating diseases related to Transforming Growth Factor-beta (TGF-β).
Latest Patents
Masahiro Miura holds a patent for an isolated monoclonal antibody against a human Transforming Growth Factor-β (TGF-β) Latency Associated Protein (LAP) degradate. This innovative antibody is capable of recognizing an integrin binding site in the human TGF-β LAP degradate. This patent represents a crucial advancement in therapeutic strategies targeting TGF-β related pathways.
Career Highlights
Throughout his career, Miura has worked with esteemed organizations such as RIKEN Corporation and The Jikei University. His roles in these institutions have allowed him to engage in cutting-edge research and development, contributing to the advancement of scientific knowledge in his field.
Collaborations
Some of his notable coworkers include Ikuyo Inoue and Soichi Kojima. Their collaborative efforts have further enriched the research environment and fostered innovation in antibody development.
Conclusion
Masahiro Miura's work in monoclonal antibody research exemplifies the impact of innovative thinking in biotechnology. His contributions continue to influence the scientific community and pave the way for future advancements in medical treatments.